You are here

Article info

Article menu

Download PDFPDF

XML
Recent advances in basic science
Epigenetics in liver disease: from biology to therapeutics

Authors

  • Timothy Hardy Fibrosis Laboratories, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK Department of Gastroenterology and Hepatology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK PubMed articlesGoogle scholar articles
  • Derek A Mann Fibrosis Laboratories, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Derek A Mann, Fibrosis Laboratories, Institute of Cellular Medicine, 4th Floor William Leech Bdg., Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, UK; derek.mann{at}ncl.ac.uk
View Full Text

Citation

Hardy T, Mann DA
Epigenetics in liver disease: from biology to therapeutics
Gut 2016;65:1895-1905.

Publication history

  • Received July 28, 2016
  • Revised July 29, 2016
  • Accepted August 1, 2016
  • First published September 13, 2016.
Online issue publication 
December 22, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/